News

'Miracle' HIV drug lenacapavir approved amid US budget cuts
The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
Durban's young health professionals lead the way in HIV prevention and clinical trials
Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...
San Francisco Examiner17h
Coverage questions mute enthusiasm for HIV drug approval
Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...
The Pharma Letter18h
Yeztugo holds potential to address key unmet needs for PrEP usage
Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...
The Observer21h
Ugandan firm to manufacture $28,000 HIV drug for just $50
In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...